Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 13 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact13 DOIs

Deposit reference lists for 3 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact3 DOIs

DOIs for this ISSN

Showing the top 5 of 266 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Therapeutic Use of Palmitoylethanolamide as an Anti-Inflamma… (10.3390/futurepharmacol3040058)	ORCID	34.51	23
2	Ocular Drug Delivery into the Eyes Using Drug-Releasing Soft… (10.3390/futurepharmacol4020019)	ORCID	25.00	9
3	Acute Promyelocytic Leukemia (APL): A Review of the Classic… (10.3390/futurepharmacol3010012)	ORCID	23.86	8
4	Carrier-Mediated Delivery of Low-Molecular-Weight N-Containi… (10.3390/futurepharmacol3040046)	ORCID	19.45	5
5	Potentially Remediable Shortcomings in the Contemporary Drug… (10.3390/futurepharmacol2040035)	ORCID	11.93	2
6	Transplacental Treatment of Fetal Tachyarrhythmia: Current T… (10.3390/futurepharmacol3020027)	ORCID	11.93	2
7	Tolerability and Efficacy of Multiple Series of Intravitreal… (10.3390/futurepharmacol3020029)	ORCID	11.93	2
8	Design of a Cyclodextrin Bioproduction Process Using Bacillu… (10.3390/futurepharmacol3030035)	ORCID	11.93	2
9	Sex-Specific Responses to Tacrolimus and Mycophenolate Mofet… (10.3390/futurepharmacol3040052)	ORCID	11.93	2
10	Substance Delivery across the Blood-Brain Barrier or the Blo… (10.3390/futurepharmacol4030027)	ORCID	11.93	2
11	A Synergistic Antibacterial Platform Combining Low–Temperatu… (10.3390/futurepharmacol3010013)	ORCID	7.53	1
12	The New Future Pharmacology Journal: A Cutting-Edge Opportun… (10.3390/futurepharmacol1010001)		0.00	0
13	Mitochondrial Transplantation: Is It a Feasible Therapy to P… (10.3390/futurepharmacol1010002)		0.00	10
14	Kiwifruit (Actinidia spp.) Dietary Consumption for Constipat… (10.3390/futurepharmacol1010003)		0.00	3
15	An Investigation into the Impact of a Glutaminase Inhibitor,… (10.3390/futurepharmacol1010004)		0.00	3
16	Clinical Demonstrations of Controlled-Release Tablets Constr… (10.3390/futurepharmacol1010005)		0.00	4
17	Virtual Screening of Adenylate Kinase 3 Inhibitors Employing… (10.3390/futurepharmacol1010006)		0.00	0
18	Recent Advances in Mupirocin Delivery Strategies for the Tre… (10.3390/futurepharmacol1010007)		0.00	42
19	Exploring the Pharmacological Potential of Glycyrrhizic Acid… (10.3390/futurepharmacol2010001)		0.00	43
20	Antioxidant and Antifungal Activity of the Cynophalla flexuo… (10.3390/futurepharmacol2010002)		0.00	3
21	Unraveling Drug Response from Pharmacogenomic Data to Advanc… (10.3390/futurepharmacol2010003)		0.00	5
22	Increased Production of Taxoids in Suspension Cultures of Ta… (10.3390/futurepharmacol2010004)		0.00	21
23	Multi-Donor Fecal Microbial Transplantation for Critically I… (10.3390/futurepharmacol2010005)		0.00	3
24	A Fresh Look on Bergenin: Vision of Its Novel Drug Delivery… (10.3390/futurepharmacol2010006)		0.00	21
25	Drug Repositioning in Intensive Care Patients and Pharmacoki… (10.3390/futurepharmacol2010007)		0.00	0
26	In Silico Personalized Study for Zolpidem Based on Sex Diffe… (10.3390/futurepharmacol2020008)		0.00	3
27	Snake Venom and 3D Microenvironment Cell Culture: From Produ… (10.3390/futurepharmacol2020009)		0.00	4
28	Single Cell Plant Model of Equisetum arvense for the Study A… (10.3390/futurepharmacol2020010)		0.00	2
29	Pharmacogenetic Perspective for Optimal Gout Management (10.3390/futurepharmacol2020011)		0.00	15
30	Primary Obsessive Slowness: A Complex Presentation and Treat… (10.3390/futurepharmacol2020012)		0.00	0
31	In Silico ADME Profiling of Salubrinal and Its Analogues (10.3390/futurepharmacol2020013)		0.00	51
32	The Role of Lactic Acid in the Management of Bacterial Vagin… (10.3390/futurepharmacol2030014)		0.00	13
33	Therapeutic Potential of Mitotic Kinases’ Inhibitors in Canc… (10.3390/futurepharmacol2030015)		0.00	4
34	Oxostephanine, Thalmiculine, and Thaliphyline—Three Isoquino… (10.3390/futurepharmacol2030016)		0.00	1
35	Promising Therapeutic Strategies Targeting Mitochondria in K… (10.3390/futurepharmacol2030017)		0.00	7
36	The Pharmacogenetics of Treatment with Quetiapine (10.3390/futurepharmacol2030018)		0.00	13
37	Pandemic Preparedness: The Potential Advantage of Medicines… (10.3390/futurepharmacol2030019)		0.00	2
38	Azapeptides as an Efficient Tool to Improve the Activity of… (10.3390/futurepharmacol2030020)		0.00	15
39	A Computational Approach for Molecular Characterization of C… (10.3390/futurepharmacol2030021)		0.00	4
40	Bioactivity of Ionic Liquids Based on Valproate in SH-SY5Y H… (10.3390/futurepharmacol2030022)		0.00	2
41	The Charge and Phase State of Liposomes Dramatically Affects… (10.3390/futurepharmacol2030023)		0.00	8
42	The Influence of Cannabinoids on Multiple Myeloma Cells: A S… (10.3390/futurepharmacol2030024)		0.00	2
43	Strategies for Generating Human Pluripotent Stem Cell-Derive… (10.3390/futurepharmacol2030025)		0.00	8
44	Implications and Practical Applications of the Chemical Spec… (10.3390/futurepharmacol2040026)		0.00	10
45	Dendrimers-Based Drug Delivery System: A Novel Approach in A… (10.3390/futurepharmacol2040027)		0.00	11
46	A Critical Review of Chloroquine and Hydroxychloroquine as P… (10.3390/futurepharmacol2040028)		0.00	33
47	Macrophage Delivered HSV1716 Is Active against Triple Negati… (10.3390/futurepharmacol2040029)		0.00	5
48	Preventing Microbial Infections with Natural Phenolic Compou… (10.3390/futurepharmacol2040030)		0.00	153
49	Effect of Etanercept on Plasmodium yoelii MDR-Induced Liver… (10.3390/futurepharmacol2040031)		0.00	2
50	A Mechanistic Insight on Phytoconstituents Delivering Hypogl… (10.3390/futurepharmacol2040032)		0.00	11